ASX CODE: IHL
Impression Healthcare files patent application for medicinal CBD drug to alleviate concussion injuries
Impression Healthcare (ASX: IHL) has opted to file a patent application for a neuroprotective agent that could potentially aid people that suffer concussions – a...
Duo of renowned specialists join Impression Healthcare, Incannex CBD oils on route
Following a busy few months on the recruitment and brand licencing fronts, Impression Healthcare (ASX: IHL) has appointed an additional duo of leading medical...
Impression Healthcare appoints two globally renowned medical experts for cannabis medicines projects
Impression Healthcare (ASX: IHL) has bolstered its Medical Advisory Board by appointing two leading medical experts possessing extensive expertise within two key market niches currently being...
Impression Healthcare commences obstructive sleep apnoea clinical trial
Following last week’s deal that saw Impression Healthcare (ASX: IHL) secure the cannabinoid materials it needs to conduct a series of clinical trials, the...
Impression Healthcare secures long term oil supply agreement, unveils new cannabis discovery brand Incannex
Impression Healthcare (ASX: IHL) has moved to extend its medicinal cannabis market coverage after unveiling the all-new cannabinoid drug discovery brand Incannex Pharmaceuticals.
As a...
Impression Healthcare becomes official supplier and research partner to ONE Championship
Barely a week after Aurora announced a deal with the Ultimate Fighting Championship (UFC), Australia’s very own Impression Healthcare (ASX: IHL) has made a...
Impression Healthcare appoints leading medicinal cannabis pioneer Dr Sud Agarwal to its board
Impression Healthcare (ASX: IHL) has tweaked its internal structure by appointing Dr Sud Agarwal, a leading figure in the medicinal cannabis industry as its...
Impression Healthcare extends exclusive deal with FiTGuard for concussion monitoring
Impression Healthcare (ASX: IHL) has extended the global coverage of its Fitguard by Gameday concussion monitoring system by extending its exclusive licencing agreement with...
Impression Healthcare hones in on sleep apnoea trial with proprietary Dronabinol formulation
Impression Healthcare (ASX: IHL) is on the brink of conducting a sleep apnoea trial with its own variant of the cannabinoid medicine Dronabinol after...
Impression Healthcare becomes Boxing Australia’s official supplier and concussion research partner
Impression Healthcare (ASX: IHL) has unveiled a brand-new exclusive research and supply agreement that will see the healthcare company become the official traumatic brain...
Impression Healthcare registers clinical trial for CBD-based mouthwash and toothpaste
Impression Healthcare’s (ASX: IHL) “world first” clinical trial using its cannabidiol (CBD)-based mouthwash and toothpaste to treat gingivitis and periodontitis (gum disease) has now...
Impression Healthcare to supply concussion monitoring FitGuard mouthguard system
Impression Healthcare (ASX: IHL) has inked an exclusive agreement to supply the concussion monitoring FitGuard mouthguard system.
Under the agreement with Force Impact Technologies, Impression...
Impression Healthcare signs first binding agreement with AXIM Biotechnologies, clinical trial imminent
Impression Healthcare (ASX: IHL) is set to deliver a toothpaste and mouthwash product that adds yet another option for consumers searching for cannabidiol-based products.
Earlier...
Impression Healthcare aims for competitive edge over ‘cure-all’ suppliers with unique medical cannabis trials
Impression Healthcare (ASX: IHL) is on the road to gaining a competitive edge in the medicinal cannabis field with four upcoming trials aimed at...
Impression Healthcare teams up with Cannvalate in ‘first of its kind’ medical cannabis trial and distribution...
Disruptive healthcare company Impression Healthcare (ASX: IHL) has teamed up with Australia’s largest network of medical cannabis clinics, Cannvalate, to distribute cannabinoid (CBD) medicines...
Impression Healthcare signs deal to progress cannabis medicine ‘dronabinol’ towards treatment of sleep apnoea
Impression Healthcare’s (ASX: IHL) dronabinol project has taken on anther dimension after the company signed a memorandum of understanding and exclusivity agreement with RespireRx...
Impression Healthcare scores exclusive supply agreement with corporate dentist 1300SMILES
Impression Healthcare (ASX: IHL) has recently made a lot of moves in the medicinal cannabis space, including receiving its cannabis distribution licenses last week.
This...
Impression Healthcare secures licences to facilitate medical cannabis activities
One of Australia’s newest entrants to the medical cannabis industry, Impression Healthcare (ASX: IHL), has reached what it says is an important milestone in...
Impression Healthcare strikes cornerstone deal for next generation of FiTGuard mouthguards
Dental impression company Impression Healthcare (ASX: IHL) has kicked off 2019 with a deal with Force Impact Technologies, a US-based life science company.
The deal intends...
Impression Healthcare widens operations for international expansion
Impression Healthcare (ASX: IHL) announced this morning that it has formally lodged its application to possess and supply “scheduled substances”, namely cannabinoids, in Australia.
Once...
Impression Healthcare signs exclusive licensing deal to market America’s first ever cannabinoid medication
The commercial landscape is shifting rapidly for Impression Healthcare (ASX: IHL), as the dental impression company continues its foray into medicinal cannabis.
Impression manufacturers a...
